Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease

Dong Fan1, Abhijit Takawale, Jiwon Lee

  • 1Department of Physiology, University of Alberta, Edmonton, AB, T6G 2S2, Canada. z.kassiri@ualberta.ca.

Insights

Cardiac fibroblasts are key players in heart disease, contributing to fibrosis through extracellular matrix (ECM) production. Understanding their origins and roles in ECM remodeling is crucial for developing new therapies.

Area of Science:

  • Cardiovascular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Fibroblasts are the most abundant cells in the heart myocardium.
  • Cardiac fibroblast proliferation, migration, and transformation contribute to increased fibroblast numbers in heart disease.
  • Fibroblasts produce extracellular matrix (ECM) proteins, and their hyperactivity leads to cardiac fibrosis.

Purpose of the Study:

  • To review the function of cardiac fibroblasts in ECM formation, homeostasis, and remodeling.
  • To discuss the origins and roles of cardiac fibroblasts in myocardial remodeling across various heart diseases.
  • To provide an overview of insights gained from animal models and genetically modified mice.

Main Methods:

  • Literature review focusing on cardiac fibroblast function and ECM regulation.
  • Analysis of data from patient studies and animal models of heart disease.
  • Examination of findings from genetically modified mice with altered ECM regulatory proteins, MMPs, and TIMPs.

Main Results:

  • Cardiac fibroblasts are central to ECM production and turnover in the heart.
  • Fibroblast hyperactivity drives cardiac fibrosis, impacting cardiac structure and function.
  • Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) play critical roles in regulating fibroblast function and ECM homeostasis.

Conclusions:

  • Cardiac fibroblasts are essential mediators of myocardial remodeling in heart disease.
  • Understanding fibroblast origins and their interaction with ECM regulatory proteins is vital for therapeutic strategies.
  • Further research using experimental models will elucidate fibroblast roles in cardiac pathology.

Related Concept Videos

Extracellular Matrix01:26

Extracellular Matrix

Unlike epithelial tissue, which is composed of cells closely packed with little or no extracellular space in between, connective tissue cells are dispersed in a matrix. This extracellular matrix (ECM) is composed of fibrous proteins like collagen, elastin, and fibronectin in a ground substance consisting of interstitial fluid, cell adhesion proteins, and proteoglycans. The proteoglycans form a gel-like material in the spaces between cells and provide hydration, buffering, binding, and force...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
The Extracellular Matrix01:42

The Extracellular Matrix

Overview
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...